Preclinical validation of Oncodesign’s first radiotracer prior to human application

17/12/15

DOWNLOAD

Oncodesign presents novel LRRK2 inhibitor jointly discovered with Ipsen at the 2015 Neurosciences meeting in Chicago

21/10/15

DOWNLOAD

Oncodesign pursues its strategy of expansion in North America

16/10/15

DOWNLOAD

First half 2015 results: significant improvement alongside R&D intensification

15/09/15

DOWNLOAD